Mesirow Financial Investment Management, Inc.

Position in NVS — Novartis AG

CIK 1469475 CHICAGO, IL

Back to NVS Full portfolio

Position in NVS

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$680,321

-$642,494 QoQ

Shares Held

4,341

-49.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#762

of 1,603 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Mesirow Financial Investment Management, Inc. holds $112,278,631 across 12 Drug Manufacturers - General names. NVS ranks #10 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	158,995	$40,009,501
2	JNJ	Johnson & Johnson	115,650	$29,371,630
3	LLY	ELI LILLY & Co	15,088	$18,097,001
4	PFE	Pfizer Inc	399,667	$9,623,981
5	AMGN	Amgen Inc	14,518	$5,257,258
6	MRK	Merck & Co., Inc.	39,351	$5,056,603
7	BMY	Bristol Myers Squibb Co	32,023	$1,845,165
8	GSK	GSK plc	17,087	$895,700

All Filings in NVS

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$680,321	4,341	-49.9%	Shares	Sole	2026-07-22
2026-03-31	$1,322,815	8,660	+87.5%	Shares	Sole	2026-04-21
2025-12-31	$636,821	4,619	-0.2%	Shares	Sole	2026-02-05
2025-09-30	$593,751	4,630	0.0%	Shares	Sole	2025-11-12
2025-06-30	$560,276	4,630	-0.9%	Shares	Sole	2025-08-04
2025-03-31	$520,946	4,673	-2.1%	Shares	Sole	2025-05-08
2024-12-31	$464,460	4,773	+4.4%	Shares	Sole	2025-02-07
2024-09-30	$525,986	4,573	+2.7%	Shares	Sole	2024-11-01
2024-06-30	$474,172	4,454	-7.6%	Shares	Sole	2024-08-09
2024-03-31	$466,238	4,820	+24.8%	Shares	Sole	2024-04-25
2023-12-31	$389,845	3,861	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.